"Can Ozempic Actually Help With Fibromyalgia Pain?" What the 2026 Clinical Data Reveals About GLP-1 Drugs

A large-scale 2026 study of over 96,000 fibromyalgia patients found that GLP-1 receptor agonists—the drug class behind Ozempic and Wegovy—were associated with reduced opioid use and lower symptom burden. Here's what the clinical data actually shows.